Nuran Diril

450 total citations
19 papers, 400 citations indexed

About

Nuran Diril is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Nuran Diril has authored 19 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Nuran Diril's work include Cancer therapeutics and mechanisms (8 papers), Synthesis and Biological Evaluation (6 papers) and Synthesis and biological activity (5 papers). Nuran Diril is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), Synthesis and Biological Evaluation (6 papers) and Synthesis and biological activity (5 papers). Nuran Diril collaborates with scholars based in Türkiye. Nuran Diril's co-authors include Esin Aki, İsmail Yalçın, İlkay Yıldız, Betül Tekiner-Gülbaş, Özlem Temiz‐Arpacı, Fatma Gümüş, Sibel Gür, Aykut Özkul, Tuğba Ertan‐Bolelli and Öztekin Algül and has published in prestigious journals such as Biomaterials, European Journal of Medicinal Chemistry and Experimental Gerontology.

In The Last Decade

Nuran Diril

18 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nuran Diril Türkiye 11 299 109 98 32 22 19 400
Peter T. Rye United States 10 105 0.4× 152 1.4× 66 0.7× 16 0.5× 15 0.7× 11 326
Israil Pendrak United States 9 255 0.9× 201 1.8× 39 0.4× 34 1.1× 20 0.9× 15 431
Meng‐Xue Wei China 11 253 0.8× 85 0.8× 39 0.4× 12 0.4× 13 0.6× 27 371
Joyeeta Roy United States 11 305 1.0× 80 0.7× 26 0.3× 28 0.9× 14 0.6× 16 419
Akash P. Sakla India 13 500 1.7× 152 1.4× 46 0.5× 36 1.1× 39 1.8× 23 586
Hala M. Aly Egypt 13 463 1.5× 118 1.1× 48 0.5× 21 0.7× 11 0.5× 21 542
T. Prashanth India 12 251 0.8× 113 1.0× 41 0.4× 28 0.9× 13 0.6× 35 364
Shaojuan Jia United States 6 305 1.0× 91 0.8× 31 0.3× 33 1.0× 14 0.6× 6 391
Z. M. Nofal Egypt 8 339 1.1× 81 0.7× 37 0.4× 19 0.6× 13 0.6× 11 419
Alessandra Cirla Italy 4 149 0.5× 117 1.1× 70 0.7× 18 0.6× 16 0.7× 5 273

Countries citing papers authored by Nuran Diril

Since Specialization
Citations

This map shows the geographic impact of Nuran Diril's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuran Diril with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuran Diril more than expected).

Fields of papers citing papers by Nuran Diril

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nuran Diril. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuran Diril. The network helps show where Nuran Diril may publish in the future.

Co-authorship network of co-authors of Nuran Diril

This figure shows the co-authorship network connecting the top 25 collaborators of Nuran Diril. A scholar is included among the top collaborators of Nuran Diril based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nuran Diril. Nuran Diril is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Temiz‐Arpacı, Özlem, et al.. (2022). Evaluation of Mutagenic Activities of Antimicrobial Benzoxazole Derivatives. Pharmaceutical Chemistry Journal. 56(9). 1192–1198. 2 indexed citations
2.
Özen, Çigdem, Betül Tekiner-Gülbaş, İlkay Yıldız, et al.. (2019). Benzoxazines as new human topoisomerase I inhibitors and potential poisons. DARU Journal of Pharmaceutical Sciences. 28(1). 65–73. 13 indexed citations
3.
Ertan‐Bolelli, Tuğba, et al.. (2018). Inhibition of DNA Topoisomerases by a Series of Benzoxazoles and their Possible Metabolites. Letters in Drug Design & Discovery. 15(11). 1155–1162. 3 indexed citations
4.
Ertan‐Bolelli, Tuğba, et al.. (2018). Biological evaluation and pharmacophore modeling of some benzoxazoles and their possible metabolites. Archiv der Pharmazie. 351(2). 14 indexed citations
5.
Özen, Çigdem, et al.. (2013). Genotoxic potentials and eukaryotic DNA topoisomerase I inhibitory effects of some benzoxazine derivatives. Medicinal Chemistry Research. 23(1). 480–486. 11 indexed citations
6.
Özen, Çigdem, Betül Tekiner-Gülbaş, İlkay Yıldız, et al.. (2013). Benzothiazole derivatives as human DNA topoisomerase IIα inhibitors. Medicinal Chemistry Research. 22(12). 5798–5808. 15 indexed citations
7.
Tekiner-Gülbaş, Betül, Özlem Temiz‐Arpacı, Tuğba Ertan‐Bolelli, et al.. (2008). Some benzoxazoles and benzimidazoles as DNA topoisomerase I and II inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 23(1). 37–42. 110 indexed citations
8.
Tekiner-Gülbaş, Betül, Özlem Temiz‐Arpacı, İlkay Yıldız, et al.. (2007). QSAR of genotoxic active benzazoles§. SAR and QSAR in environmental research. 18(3-4). 251–263. 12 indexed citations
9.
Temiz‐Arpacı, Özlem, Betül Tekiner-Gülbaş, İlkay Yıldız, et al.. (2007). A study on the genotoxic activities of some new benzoxazoles. Medicinal Chemistry Research. 16(1). 1–14. 44 indexed citations
10.
Gümüş, Fatma, Tuncel ÖZDEN, Serap Süzük Yıldız, et al.. (2003). Synthesis, characterization and in vitro cytotoxic, mutagenic and antimicrobial activity of platinum(II) complexes with substituted benzimidazole ligands. Journal of Inorganic Biochemistry. 94(3). 255–262. 55 indexed citations
11.
Diril, Nuran, et al.. (2003). Mutagenic potentials of dental cements as detected by the Salmonella/microsome test. Biomaterials. 25(18). 4019–4027. 16 indexed citations
12.
Keskin, Nevіn, et al.. (2003). Detection of Mutagenic Activities of Various Pesticides in Neurospora crassa. Bulletin of Environmental Contamination and Toxicology. 70(1). 22–33. 2 indexed citations
13.
Gümüş, Fatma, Öztekin Algül, Gökçen Eren, et al.. (2003). Synthesis, cytotoxic activity on MCF-7 cell line and mutagenic activity of platinum(II) complexes with 2-substituted benzimidazole ligands. European Journal of Medicinal Chemistry. 38(5). 473–480. 75 indexed citations
14.
Gümüş, Fatma, et al.. (2003). Synthesis, characterization and mutagenicity of new cis-[Pt(2-substituted-benzimidazole)2Cl2] complexes.. PubMed. 58(5). 303–7. 6 indexed citations
15.
Diril, Nuran, et al.. (2000). Mutagenic Effects of Plant Growth Hormones with the Salmonella/Microsome Test and the SOS Chromotest. Bulletin of Environmental Contamination and Toxicology. 65(6). 691–698. 1 indexed citations
17.
Diril, Nuran, et al.. (1995). Age-related activity of catalase in different genotypes of drosophila melanogaster. Experimental Gerontology. 30(1). 77–86. 14 indexed citations
18.
Diril, Nuran, et al.. (1995). Investigation of cytotoxic, mutagenic and antimutagenic effects of ascorbic acid, cu(II) and aspirin by salmonelia mutagenicity assay. Toxicological & Environmental Chemistry Reviews. 52(1-4). 215–220. 1 indexed citations
19.
Diril, Nuran, et al.. (1990). [The mutagenicity of some insecticides in the Salmonella/microsome test system].. PubMed. 24(2). 103–10. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026